Valeant seeks more tuck-in acquisitions

15 August 2013 - Deborah Wilkes

Archived

Valeant Pharmaceuticals International is exploring both tuck-in acquisitions and a merger of equals following its US$8.7 billion purchase of global eye health specialist Bausch + Lomb.

Click tags below for more information on topics:

Bausch Health

Annual Subscription Holder?

Sign in to continue reading.
 

Sign In

Back to Industry News

Share this page: